CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in St. Gallen, Switzerland, CSL Vifor also includes the joint company Vifor Fresenius Medical Care Renal Pharma (with Fresenius Medical Care).
The parent company, CSL (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries. For more information about CSL Vifor visit, www.cslvifor.com.
www.viforpharma.com The parent company, CSL (ASX:CSL; USOTC:CSLLY), headquartered in Melbourne, Australia, employs 32,000 people and delivers its lifesaving therapies to people in more than 100 countries. For more information about CSL Vifor visit, www.cslvifor.com.
AMOUNT: 40.000 Euros
CSL Vifor supports the Nephro Update Europe 2025 as Partner.
CSL Vifor supports the Nephro Update Europe 2025 as Partner.
About MEDICE - The Health Family
For over 75 years, MEDICE has stood for working together to improve people's health. As a medium-sized family business in its third generation, the MEDICE Health Family pursues the goal of creating a healthier world by considering and promoting the various dimensions of health - mental/physical, social and ecological - in an all-encompassing way.
Quality ‘Made in Germany’: MEDICE develops and produces high-quality medicinal products and medical devices in the prescription (RX) and self-medication (PCC) sectors at its company sites in Iserlohn and Ringelheim and markets them successfully both nationally and internationally. The patient is always at the center of the company's activities.
The patient is at the center of the MEDICE Health Family's efforts. In order to further improve patient care, MEDICE uses its pharmacological expertise to develop clinically validated multimodal healthcare solutions that combine pharmaceuticals, digital solutions and nutritional concepts. In this way, the company helps to close gaps in care and supports people at every stage of their illness. This is supported by the establishment of the important pillars Medigital and Medibiom.
The entrepreneurial activities of the MEDICE Health Family are inextricably linked to its social commitment. For decades, MEDICE has not only promoted sport and culture for social health through various (mostly regional) projects, but also the valorization of natural areas and the use of sustainable dispensing articles for ecological health through sustainable4U GmbH, which was founded specifically for this purpose. The values of the MEDICE Health Family - future-focused, value-creating and family-oriented - guide the company here.
Based on its long-standing tradition as a family business, MEDICE - The Health Family aims to play a tangible role in shaping the future of medicine in the coming decade.
www.medice.com For over 75 years, MEDICE has stood for working together to improve people's health. As a medium-sized family business in its third generation, the MEDICE Health Family pursues the goal of creating a healthier world by considering and promoting the various dimensions of health - mental/physical, social and ecological - in an all-encompassing way.
Quality ‘Made in Germany’: MEDICE develops and produces high-quality medicinal products and medical devices in the prescription (RX) and self-medication (PCC) sectors at its company sites in Iserlohn and Ringelheim and markets them successfully both nationally and internationally. The patient is always at the center of the company's activities.
The patient is at the center of the MEDICE Health Family's efforts. In order to further improve patient care, MEDICE uses its pharmacological expertise to develop clinically validated multimodal healthcare solutions that combine pharmaceuticals, digital solutions and nutritional concepts. In this way, the company helps to close gaps in care and supports people at every stage of their illness. This is supported by the establishment of the important pillars Medigital and Medibiom.
The entrepreneurial activities of the MEDICE Health Family are inextricably linked to its social commitment. For decades, MEDICE has not only promoted sport and culture for social health through various (mostly regional) projects, but also the valorization of natural areas and the use of sustainable dispensing articles for ecological health through sustainable4U GmbH, which was founded specifically for this purpose. The values of the MEDICE Health Family - future-focused, value-creating and family-oriented - guide the company here.
Based on its long-standing tradition as a family business, MEDICE - The Health Family aims to play a tangible role in shaping the future of medicine in the coming decade.
Medice supports the Nephro Update Europe 2025 as Partner.
Boehringer Ingelheim is driven by the desire to serve humankind by improving human and animal health. As a successful, family owned company BI plans in generations. They work together globally and with integrity.
www.boehringer-ingelheim.com Boehringer Ingelheim supports the Nephro Update Europe 2025 as Partner.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our proven Generics, we ensure that everyday health remains affordable.
www.stada.com Stada supports the Nephro Update Europe 2025 as Partner.
For more than 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines and delivery systems, like our insulin pens.
www.novonordisk.com Our treatments today are benefiting millions of people living with diabetes, obesity, and rare blood and endocrine diseases.
From our labs to our factory floors, we are discovering and developing innovative biological medicines and making them accessible to patients throughout the world.
Novo Nordisk supports the Nephro Update Europe 2025 as Partner.
Sobi is a global biopharma company transforming the lives of people with rare and debilitating diseases.
www.sobi.com Sobi supports the Nephro Update Europe 2025 as Partner.
